I have no doubt........
that bioMETRX is diluting stock. At this stage every pink dilutes in order to raise capital, but it is premature to state whether any of the financing or dilution that is taking place is toxic because there are no real numbers out yet. The real questions I have is are the products being adopted in the marketplace and are sales ramping up? I would have to say that the articles showing new and re-orders at bioMETRX are impressive but as we have seen in another biometrics company which is now defunked, it is now time for them to put the money where "da" mouth is and keep that revenue growing!
As to being in bed with Crestview, let's hope that the interest on the loan isn't at loan shark rates like it was at the other company, especially when interest rates are at an all time low otherwise that would be a huge clue!!!!!!!!!!
Looking forward to the report.......
GL Everyone